- Home
- MRK vs ICUCW Comparison
MRK vs ICUCW Comparison
Compare MRK & ICUCW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRK
- ICUCW
- Stock Information
- Founded
- MRK 2000
- ICUCW N/A
- Country
- MRK United States
- ICUCW United States
- Employees
- MRK N/A
- ICUCW 19
- Industry
- MRK Biotechnology: Pharmaceutical Preparations
- ICUCW Biotechnology: Pharmaceutical Preparations
- Sector
- MRK Health Care
- ICUCW Health Care
- Exchange
- MRK Nasdaq
- ICUCW Nasdaq
- Market Cap
- MRK 198.5B
- ICUCW N/A
- IPO Year
- MRK N/A
- ICUCW 2021
- Fundamental
- Price
- MRK $81.00
- ICUCW N/A
- Analyst Decision
- MRK Buy
- ICUCW
- Analyst Count
- MRK 15
- ICUCW 0
- Target Price
- MRK $113.71
- ICUCW N/A
- AVG Volume (30 Days)
- MRK 18.0M
- ICUCW N/A
- Earning Date
- MRK 07-29-2025
- ICUCW N/A
- Dividend Yield
- MRK 4.00%
- ICUCW N/A
- EPS Growth
- MRK 667.14
- ICUCW N/A
- EPS
- MRK 6.88
- ICUCW N/A
- Revenue
- MRK $63,922,000,000.00
- ICUCW N/A
- Revenue This Year
- MRK $2.42
- ICUCW N/A
- Revenue Next Year
- MRK $5.77
- ICUCW N/A
- P/E Ratio
- MRK $11.77
- ICUCW N/A
- Revenue Growth
- MRK 4.10
- ICUCW N/A
- 52 Week Low
- MRK $73.31
- ICUCW N/A
- 52 Week High
- MRK $129.93
- ICUCW N/A
- Technical
- Relative Strength Index (RSI)
- MRK 54.36
- ICUCW N/A
- Support Level
- MRK $78.14
- ICUCW N/A
- Resistance Level
- MRK $83.07
- ICUCW N/A
- Average True Range (ATR)
- MRK 1.84
- ICUCW 0.00
- MACD
- MRK 0.21
- ICUCW 0.00
- Stochastic Oscillator
- MRK 64.15
- ICUCW 0.00
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
About ICUCW SeaStar Medical Holding Corporation Warrant
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.